AUVIP
Applied UV, Inc. [AUVIP] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AUVIP Stock Summary
Top 10 Correlated Stocks
AUVIP
In the News
AUVIP Financial details
Company Rating
Sell
Market Cap
3.14M
Income
-26.69M
Revenue
37.94M
Book val./share
60.83
Cash/share
4.14
Dividend
-
Dividend %
-
Employees
115
Optionable
No
Shortable
Yes
Earnings
31 Dec 2022
P/E
-1.22
Forward P/E
-
PEG
-0.11
P/S
0.09
P/B
1.08
P/C
1.69
P/FCF
-0.35
Quick Ratio
0.25
Current Ratio
0.51
Debt / Equity
0.6
LT Debt / Equity
0.29
-
-
EPS (TTM)
-206.54
EPS next Y
-
EPS next Q
-
EPS this Y
116.91%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
21.66%
Revenue Q/Q
5.55%
EPS Q/Q
-59.22%
-
-
-
-
SMA20
40%
SMA50
75%
SMA100
133.33%
Inst Own
-
Inst Trans
-
ROA
-28%
ROE
-91%
ROC
-0.41%
Gross Margin
20%
Oper. Margin
-32%
Profit Margin
-53%
Payout
-6%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.31-21.96
52W High
-66.67%
52W Low
+600%
RSI
65
Rel Volume
0.25
Avg Volume
4.52K
Volume
1.12K
Perf Week
34.62%
Perf Month
54.87%
Perf Quarter
192.87%
Perf Half Y
221.1%
-
-
-
-
Beta
-1.377
-
-
Volatility
0.15%, 1%
Prev Close
0%
Price
7
Change
4.48%
AUVIP Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 5.91 | 233.18 | 90.19 | 157.27 | 197.37 | |
| Net income per share | 0.56 | 70.02 | -53 | -99.62 | -216.09 | |
| Operating cash flow per share | 0.41 | 19.25 | -10.34 | -94.33 | -85.62 | |
| Free cash flow per share | 0.41 | 18.93 | -13.78 | -94.72 | -85.85 | |
| Cash per share | 0.62 | 25.74 | 184.99 | 106.8 | 26.8 | |
| Book value per share | -1.11 | 34.61 | 153.47 | 440.32 | 168.9 | |
| Tangible book value per share | -1.11 | 34.61 | 150.67 | 119.69 | 21.14 | |
| Share holders equity per share | -1.11 | 34.61 | 153.47 | 440.32 | 168.9 | |
| Interest debt per share | 0.05 | 20.23 | 14.96 | 25.63 | 79 | |
| Market cap | 1.85B | 58.01M | 36.47M | 25.04M | 11.54M | |
| Enterprise value | 1.85B | 57.78M | 25.66M | 19.02M | 16.58M | |
| P/E ratio | 2.57K | 20.71 | -10.83 | -3.39 | -0.52 | |
| Price to sales ratio | 245.35 | 6.22 | 6.36 | 2.15 | 0.57 | |
| POCF ratio | 3.51K | 75.32 | -55.49 | -3.58 | -1.32 | |
| PFCF ratio | 3.53K | 76.61 | -41.64 | -3.56 | -1.32 | |
| P/B Ratio | -1.31K | 41.89 | 3.74 | 0.77 | 0.67 | |
| PTB ratio | -1.31K | 41.89 | 3.74 | 0.77 | 0.67 | |
| EV to sales | 245.25 | 6.19 | 4.48 | 1.63 | 0.82 | |
| Enterprise value over EBITDA | 2.43K | 40.93 | -7.79 | -3.45 | -2.18 | |
| EV to operating cash flow | 3.51K | 75.01 | -39.04 | -2.72 | -1.9 | |
| EV to free cash flow | 3.53K | 76.3 | -29.3 | -2.71 | -1.89 | |
| Earnings yield | 0 | 0.05 | -0.09 | -0.3 | -1.91 | |
| Free cash flow yield | 0 | 0.01 | -0.02 | -0.28 | -0.76 | |
| Debt to equity | -0.02 | 0.57 | 0.1 | 0.06 | 0.45 | |
| Debt to assets | 0.01 | 0.17 | 0.07 | 0.05 | 0.24 | |
| Net debt to EBITDA | -1.01 | -0.17 | 3.28 | 1.09 | -0.66 | |
| Current ratio | 1.42 | 1.26 | 4.58 | 2.88 | 1.07 | |
| Interest coverage | 21.14 | 89.2 | 0 | 0 | -38.18 | |
| Income quality | 0.73 | 0.27 | 0.2 | 0.95 | 0.53 | |
| Dividend Yield | 0 | 0 | 0 | 0.02 | 0.13 | |
| Payout ratio | 0 | 0 | 0 | -0.08 | -0.07 | |
| Sales general and administrative to revenue | 0.25 | 0.21 | 0.7 | 0.9 | 0.68 | |
| Research and developement to revenue | 0 | 0 | 0.05 | 0 | 0.02 | |
| Intangibles to total assets | 0 | 0 | 0.01 | 0.62 | 0.46 | |
| Capex to operating cash flow | -0.01 | -0.02 | 0.33 | 0 | 0 | |
| Capex to revenue | 0 | 0 | -0.04 | 0 | 0 | |
| Capex to depreciation | -0.62 | -1.6 | -12.4 | -0.02 | -0.01 | |
| Stock based compensation to revenue | 0 | 0.01 | 0.12 | 0.13 | 0.04 | |
| Graham number | 3.75 | 233.51 | 427.81 | 993.46 | 906.2 | |
| ROIC | -0.55 | 0.48 | -0.3 | -0.2 | -0.49 | |
| Return on tangible assets | 0.23 | 0.59 | -0.26 | -0.5 | -1.25 | |
| Graham Net | -1.66 | -15.77 | 136.04 | 49.81 | -77.36 | |
| Working capital | 912.39K | 728.69K | 9.65M | 8.36M | 798.36K | |
| Tangible asset value | -1.42M | 1.38M | 9.58M | 8.88M | 2.16M | |
| Net current asset value | -1.45M | 112.06K | 8.98M | 6.95M | -3.17M | |
| Invested capital | -0.02 | 0.57 | 0.1 | 0.06 | 0.45 | |
| Average receivables | 0 | 2.16M | 1.23M | 609.62K | 1.9M | |
| Average payables | 0 | 1.11M | 1.32M | 1.52M | 2.31M | |
| Average inventory | 0 | 105.83K | 127.92K | 971.27K | 3.65M | |
| Days sales outstanding | 100.52 | 87.32 | 14.83 | 30.85 | 51.02 | |
| Days payables outstanding | 73.44 | 75.24 | 108.04 | 79.19 | 67.62 | |
| Days of inventory on hand | 8.37 | 6.05 | 12.08 | 86.14 | 124.86 | |
| Receivables turnover | 3.63 | 4.18 | 24.61 | 11.83 | 7.15 | |
| Payables turnover | 4.97 | 4.85 | 3.38 | 4.61 | 5.4 | |
| Inventory turnover | 43.62 | 60.37 | 30.22 | 4.24 | 2.92 | |
| ROE | -0.51 | 2.02 | -0.35 | -0.23 | -1.28 | |
| Capex per share | 0 | -0.32 | -3.44 | -0.39 | -0.23 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.46 | 46.09 | 76.86 | 61.14 | 30.6 | |
| Net income per share | -0.24 | -139.9 | -42.89 | -16.87 | -6.88 | |
| Operating cash flow per share | -0.14 | -11.64 | -23.59 | -18.65 | -3.39 | |
| Free cash flow per share | -0.14 | -11.42 | -24.13 | -18.94 | -3.89 | |
| Cash per share | 0.08 | 25.2 | 15.02 | 18.8 | 4.14 | |
| Book value per share | 2.04 | 158.83 | 170.03 | 140.79 | 60.83 | |
| Tangible book value per share | 0.35 | 19.88 | -164.96 | -117.49 | -59.85 | |
| Share holders equity per share | 2.04 | 158.83 | 170.03 | 140.79 | 60.83 | |
| Interest debt per share | 0.22 | 73.41 | 106.69 | 83.91 | 37.86 | |
| Market cap | 2.15B | 12.27M | 15.25M | 4.11M | 3.01M | |
| Enterprise value | 2.15B | 17.31M | 27.56M | 15.18M | 15.07M | |
| P/E ratio | -175.62 | -0.2 | -0.64 | -0.34 | -0.29 | |
| Price to sales ratio | 366.18 | 2.45 | 1.43 | 0.38 | 0.26 | |
| POCF ratio | -1.22K | -9.72 | -4.66 | -1.24 | -2.38 | |
| PFCF ratio | -1.21K | -9.9 | -4.56 | -1.23 | -2.07 | |
| P/B Ratio | 83.26 | 0.71 | 0.65 | 0.16 | 0.13 | |
| PTB ratio | 83.26 | 0.71 | 0.65 | 0.16 | 0.13 | |
| EV to sales | 366.47 | 3.46 | 2.59 | 1.4 | 1.32 | |
| Enterprise value over EBITDA | -1.19K | -7.17 | -11.14 | -7.25 | -11.87 | |
| EV to operating cash flow | -1.22K | -13.71 | -8.43 | -4.59 | -11.9 | |
| EV to free cash flow | -1.21K | -13.97 | -8.24 | -4.52 | -10.37 | |
| Earnings yield | 0 | -1.24 | -0.39 | -0.73 | -0.85 | |
| Free cash flow yield | 0 | -0.1 | -0.22 | -0.82 | -0.48 | |
| Debt to equity | 0.11 | 0.45 | 0.61 | 0.58 | 0.6 | |
| Debt to assets | 0.08 | 0.24 | 0.2 | 0.2 | 0.19 | |
| Net debt to EBITDA | -0.92 | -2.09 | -4.98 | -5.28 | -9.5 | |
| Current ratio | 1.41 | 1.07 | 0.52 | 0.55 | 0.51 | |
| Interest coverage | -64.13 | -18.04 | -8.99 | -5.57 | -4.39 | |
| Income quality | 0.65 | 0.14 | 0.72 | 1.11 | 0.49 | |
| Dividend Yield | 0 | 0.03 | 0.02 | 0.1 | 0 | |
| Payout ratio | -0.12 | -0.02 | -0.06 | -0.14 | 0 | |
| Sales general and administrative to revenue | 0.55 | 0.77 | 0.48 | 0.44 | 0 | |
| Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Intangibles to total assets | 0.64 | 0.46 | 0.64 | 0.63 | 0.63 | |
| Capex to operating cash flow | 0.01 | -0.02 | 0.02 | 0.02 | 0.15 | |
| Capex to revenue | 0 | 0 | -0.01 | 0 | -0.02 | |
| Capex to depreciation | -0.02 | 0.03 | -0.07 | -0.09 | -0.16 | |
| Stock based compensation to revenue | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
| Graham number | 3.33 | 707.08 | 405.06 | 231.14 | 97.03 | |
| ROIC | -0.1 | -0.19 | -0.11 | -0.07 | -0.07 | |
| Return on tangible assets | -0.25 | -0.86 | -0.22 | -0.11 | -0.1 | |
| Graham Net | -0.23 | -72.75 | -273.11 | -197.05 | -98.24 | |
| Working capital | 2.56M | 798.36K | -19.76M | -17.82M | -20.61M | |
| Tangible asset value | 4.47M | 2.16M | -22.87M | -20.84M | -22.39M | |
| Net current asset value | 1.01M | -3.17M | -28.32M | -25.81M | -27.47M | |
| Invested capital | 0.11 | 0.45 | 0.61 | 0.58 | 0.6 | |
| Average receivables | 2.23M | 2.43M | 4.83M | 7.17M | 8.25M | |
| Average payables | 2.32M | 2.6M | 5.92M | 8.86M | 9.57M | |
| Average inventory | 4.56M | 4.97M | 7.06M | 8.41M | 7.89M | |
| Days sales outstanding | 31.36 | 50.66 | 57.83 | 62.13 | 70.84 | |
| Days payables outstanding | 39.75 | 63.11 | 91.27 | 94.57 | 105.23 | |
| Days of inventory on hand | 79.25 | 116.54 | 88.74 | 87.59 | 77.51 | |
| Receivables turnover | 2.87 | 1.78 | 1.56 | 1.45 | 1.27 | |
| Payables turnover | 2.26 | 1.43 | 0.99 | 0.95 | 0.86 | |
| Inventory turnover | 1.14 | 0.77 | 1.01 | 1.03 | 1.16 | |
| ROE | -0.12 | -0.88 | -0.25 | -0.12 | -0.11 | |
| Capex per share | 0 | 0.21 | -0.55 | -0.29 | -0.5 |
AUVIP Frequently Asked Questions
What is Applied UV, Inc. stock symbol ?
Applied UV, Inc. is a US stock , located in Mount vernon of Ny and trading under the symbol AUVIP
What is Applied UV, Inc. stock quote today ?
Applied UV, Inc. stock price is $7 today.
Is Applied UV, Inc. stock public?
Yes, Applied UV, Inc. is a publicly traded company.
Company Profile
- Volume Average 4.52K
- Market Capitalization 3.14M
- Employee 115
- CEO Mr. Max Munn
- Headquarters Mount Vernon,NY,US
- IPO Date 2021-07-14
-
Website
https://www.applieduvinc.com 
Applied UV, Inc., through its subsidiaries, develops, acquires, and commercializes technology that addresses air purification and infection control in the healthcare, hospitality, commercial, municipal, and residential markets in the United States, Canada, and Europe. It operates through Disinfection and Hospitality segments. The company offers science-based solutions and products in air purification under the Airocide brand; and disinfection of hard surfaces under the Lumicide brand. It also manufactures and supplies fine decorative framed mirrors, framed arts, and bathroom vanities. The company was incorporated in 2019 and is headquartered in Mount Vernon, New York.
